Curry Koening

Curry Koening

UNVERIFIED PROFILE

Are you Curry Koening?   Register this Author

Register author
Curry Koening

Curry Koening

Publications by authors named "Curry Koening"

Are you Curry Koening?   Register this Author

41Publications

1309Reads

46Profile Views

Evaluation of Potential Serum Biomarkers of Disease Activity in Diverse Forms of Vasculitis.

J Rheumatol 2019 Sep 1. Epub 2019 Sep 1.

From Boston University, Boston, MA, USA; University of Arizona, Tucson, AZ, USA; University of Michigan, Ann Arbor, MI, USA; University of South Florida, Tampa, FL, USA; Mount Sinai Hospital, Toronto, Ontario, Canada; McMaster University, Hamilton, Ontario, Canada; University of Utah, Salt Lake City, UT, USA; Cleveland Clinic, Cleveland, OH, USA; University of Pennsylvania, Philadelphia, PA, USA; University of Pittsburgh, Pittsburgh, PA, USA; Johns Hopkins University, Baltimore, MD, USA; Mayo Clinic, Rochester, MN, USA; VA Boston Healthcare System, Boston, MA, USA. This work was sponsored by the Vasculitis Clinical Research Consortium. The Vasculitis Clinical Research Consortium (VCRC) is part of the Rare Diseases Clinical Research Network (RDCRN), an initiative of the Office of Rare Diseases Research (ORDR), National Center for Advancing Translational Science (NCATS). The VCRC is funded through collaboration between NCATS, and the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), U54 AR057319), and has received funding from the National Center for Research Resources (U54 RR019497). Additional funding for this project included RC1 AR 058303 and P60 AR047785. Dr. Merkel reports receiving funds for the following activities: Consulting: AbbVie, AstraZeneca, Biogen, Boeringher-Ingelheim, Bristol-Myers Squibb, Celgene, ChemoCentryx, Genentech/Roche, Genzyme/Sanofi, GlaxoSmithKline, InflaRx, Insmed, Jannsen, Kiniksa; Research Support: AstraZeneca, Boeringher- Ingelheim, Bristol-Myers Squibb, Celgene, ChemoCentryx, Genentech/Roche, GlaxoSmithKline, Kypha, TerumoBCT; Royalties: UpToDate. Dr. Monach reports receiving funds for the following activities: Consulting: Celgene, ChemoCentryx. Address correspondence to Paul Monach, MD, PhD Rheumatology Section VA Boston Healthcare System 150 South Huntington Ave Boston, MA 02130. Email:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.190093DOI Listing
September 2019

Feasibility and Construct Validation of the Patient Reported Outcomes Measurement Information System in Systemic Vasculitis.

J Rheumatol 2019 Aug 1;46(8):928-934. Epub 2019 Mar 1.

From the Department of Epidemiology and Biostatistics, Faculty of Medicine, University of Iceland; Department of Rheumatology, and Centre for Rheumatology Research, University Hospital, Reykjavik, Iceland; Department of Biostatistics, Epidemiology, and Informatics, and Division of Rheumatology, and Department of Family Medicine and Community Health, and Division of General Internal Medicine, University of Pennsylvania, Philadelphia; Division of Rheumatology, University of Pittsburgh, Pittsburgh, Pennsylvania; Department of Biostatistics and Informatics, Department of Pediatrics, University of South Florida, Tampa, Florida; Division of Rheumatology, University of Utah, Salt Lake City, Utah; Department of Rheumatology, Cleveland Clinic, Cleveland; Ohio State University Wexner Medical Center, Columbus, Ohio; Section of Rheumatology, Boston University School of Medicine, Boston, Massachusetts; Division of Rheumatology, and Division of Pulmonology and Critical Care Medicine, Mayo Clinic College of Medicine and Science, Rochester, Minnesota, USA; Nuffield Department of Population Health, Health Services Research Unit (HSRU), and Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford; Faculty of Health and Applied Sciences, University of the West of England, Bristol and School of Clinical Sciences, University of Bristol, Bristol, UK; Department of Rheumatology, University of Ottawa, Ottawa; Division of Rheumatology, Mount Sinai Hospital, Toronto; Division of Rheumatology, St. Joseph's Healthcare, McMaster University, Hamilton, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.171405DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6726391PMC
August 2019

The Birmingham Vasculitis Activity Score as a Measure of Disease Activity in Patients with Giant Cell Arteritis.

J Rheumatol 2016 06 1;43(6):1078-84. Epub 2016 Apr 1.

From the Division of Rheumatology, University of California, Los Angeles, Los Angeles, California; Department of Biostatistics, University of South Florida, Tampa, Florida, USA; Division of Rheumatology, Mount Sinai Hospital, Toronto, Ontario, Canada; Center for Vasculitis Care and Research, Cleveland Clinic, Cleveland, Ohio, USA; Division of Rheumatology, St. Joseph's Healthcare, McMaster University, Hamilton, Ontario, Canada; Division of Rheumatology, University of Utah, Salt Lake City, Utah; Division of Rheumatology, University of Pittsburgh, Pittsburgh, Pennsylvania; Division of Rheumatology and Clinical Immunology, University of Pennsylvania, Philadelphia, Pennsylvania; The Vasculitis Center, Section of Rheumatology, and the Clinical Epidemiology Unit, Boston University School of Medicine, Boston, Massachusetts; Division of Rheumatology, Johns Hopkins University, Baltimore, Maryland; Division of Rheumatology, Mayo Clinic College of Medicine, Rochester, Minnesota, USA.T.A. Kermani, MD, MS, Division of Rheumatology, University of California, Los Angeles; D. Cuthbertson, MS, Department of Biostatistics, University of South Florida; S. Carette, MD, FRCPC, Division of Rheumatology, Mount Sinai Hospital; G.S. Hoffman, MD, MS, Center for Vasculitis Care and Research, Cleveland Clinic; N.A. Khalidi, MD, FRCPC, Division of Rheumatology, St. Joseph's Healthcare, McMaster University; C.L. Koening, MD, MS, Division of Rheumatology, University of Utah; C.A. Langford, MD, MHS, Center for Vasculitis Care and Research, Cleveland Clinic; K. McKinnon-Maksimowicz, DO, Division of Rheumatology, University of Pittsburgh; C.A. McAlear, MA, Division of Rheumatology and Clinical Immunology, University of Pennsylvania; P.A. Monach, MD, PhD, The Vasculitis Center, Section of Rheumatology, and the Clinical Epidemiology Unit, Boston University School of Medicine; P. Seo, MD, MHS, Division of Rheumatology, Johns Hopkins University; K.J. Warrington, MD, Division of Rheumatology, Mayo Clinic

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.151063DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4891218PMC
June 2016

Serum biomarkers in patients with relapsing eosinophilic granulomatosis with polyangiitis (Churg-Strauss).

PLoS One 2015 26;10(3):e0121737. Epub 2015 Mar 26.

1st Medical Department and Ludwig Boltzmann Institute of Osteology, Hanusch Hospital, Vienna, Austria; Department of Internal Medicine 3, University of Erlangen-Nuremberg, Erlangen, Germany.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0121737PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4374913PMC
March 2016

Vasculitis in patients with inflammatory bowel diseases: A study of 32 patients and systematic review of the literature.

Semin Arthritis Rheum 2016 Feb 26;45(4):475-82. Epub 2015 Jul 26.

Division of Rheumatology, Mount Sinai Hospital, University of Toronto, The Joseph and Wolf Lebovic Building, 60 Murray St, Ste 2-220, Toronto, Ontario, Canada M5T 3L9. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.semarthrit.2015.07.006DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4982464PMC
February 2016

Absence of Bacteria in the Temporal Arteries of Patients with Giant Cell Arteritis.

J Clin Rheumatol 2016 Jan;22(1):43-4

Department of Veterans Affairs Medical Center Department of Internal Medicine University of Utah Salt Lake City, UT Department of Veterans Affairs Medical Center Department of Internal Medicine University of Utah Salt Lake City, UT Department of Microbiology Immunology and Pathology Colorado State University Fort Collins, CO Department of Microbiology Immunology and Pathology Colorado State University Fort Collins, CO and Department of Molecular Genetics and Microbiology University of Florida Gainesville, FL Molecular Medicine University of Utah Salt Lake City, UT Department of Ophthalmology and Visual Sciences University of Utah Salt Lake City, UT.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/RHU.0000000000000344DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4690527PMC
January 2016

Disease Relapses among Patients with Giant Cell Arteritis: A Prospective, Longitudinal Cohort Study.

J Rheumatol 2015 Jul 15;42(7):1213-7. Epub 2015 Apr 15.

From the Division of Rheumatology, Mayo Clinic College of Medicine, Rochester, Minnesota; Department of Biostatistics, University of South Florida, Tampa, Florida, USA; Division of Rheumatology, Mount Sinai Hospital, Toronto, Ontario, Canada; Center for Vasculitis Care and Research, Cleveland Clinic, Cleveland, Ohio, USA; Division of Rheumatology, St. Joseph's Healthcare, McMaster University, Hamilton, Ontario, Canada; Division of Rheumatology, University of Utah, Salt Lake City, Utah; Division of Rheumatology and Clinical Immunology, University of Pittsburgh, Pittsburgh, Pennsylvania; The Vasculitis Center, Section of Rheumatology, Boston University School of Medicine, Boston, Massachusetts; Division of Rheumatology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania; Division of Rheumatology, Johns Hopkins University, Baltimore, Maryland; University of California at Los Angeles (UCLA), Los Angeles, California, USA.T.A. Kermani, MD, MS, UCLA; K.J. Warrington, MD, Division of Rheumatology, Mayo Clinic College of Medicine; D. Cuthbertson, MS, Department of Biostatistics, University of South Florida; S. Carette, MD, FRCPC, Division of Rheumatology, Mount Sinai Hospital; G.S. Hoffman, MD, MS, Center for Vasculitis Care and Research, Cleveland Clinic; N.A. Khalidi, MD, FRCPC, Division of Rheumatology, St. Joseph's Healthcare, McMaster University; C.L. Koening, MD, MS, Division of Rheumatology, University of Utah; C.A. Langford, MD, MHS, Center for Vasculitis Care and Research, Cleveland Clinic; K. Maksimowicz-McKinnon, DO, Division of Rheumatology and Clinical Immunology, University of Pittsburgh; C.A. McAlear, MA, The Vasculitis Center, Section of Rheumatology, Boston University School of Medicine, and Division of Rheumatology, University of Pennsylvania School of Medicine; P.A. Monach, MD, PhD, The Vasculitis Center, Section of Rheumatology, Boston University School of Medicine; P. Seo, MD, MHS, Division of Rheumatology, Johns Hopkins University

View Article

Download full-text PDF

Source
http://www.jrheum.org/content/42/7/1213.full.pdf
Web Search
http://www.jrheum.org/cgi/doi/10.3899/jrheum.141347
Publisher Site
http://dx.doi.org/10.3899/jrheum.141347DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4505815PMC
July 2015

Cardiac Involvement in Granulomatosis with Polyangiitis.

J Rheumatol 2015 Jul 1;42(7):1209-12. Epub 2015 May 1.

From the Division of Rheumatology, Mount Sinai Hospital, Toronto, Ontario, Canada; Health Informatics Institute, University of South Florida, Tampa, Florida; Center for Vasculitis Care and Research, Cleveland Clinic, Cleveland, Ohio, USA; Division of Rheumatology, McMaster University, Hamilton, Ontario, Canada; Division of Rheumatology, University of Utah, Salt Lake City, Utah; Division of Rheumatology, University of Pennsylvania, Philadelphia; Division of Rheumatology, University of Pittsburgh, Pennsylvania; The Vasculitis Center, Section of Rheumatology, and the Clinical Epidemiology Unit, Boston University School of Medicine, Boston, Massachusetts; Division of Rheumatology, Johns Hopkins University, Baltimore, Maryland; Division of Pulmonary and Critical Care Medicine, and the Division of Rheumatology, Mayo Clinic College of Medicine, Rochester, Minnesota, USA.L. McGeoch, MD; S. Carette, MD, Division of Rheumatology, Mount Sinai Hospital; D. Cuthbertson, MS, Health Informatics Institute, University of South Florida; G.S. Hoffman, MD, Center for Vasculitis Care and Research, Cleveland Clinic; N. Khalidi, MD, Division of Rheumatology, McMaster University; C.L. Koening, MD, Division of Rheumatology, University of Utah; C.A. Langford, MD, Center for Vasculitis Care and Research, Cleveland Clinic; C.A. McAlear, MA, Division of Rheumatology, University of Pennsylvania; L. Moreland, MD, Division of Rheumatology, University of Pittsburgh; P.A. Monach, MD, PhD, The Vasculitis Center, Section of Rheumatology, and the Clinical Epidemiology Unit, Boston University School of Medicine; P. Seo, MD, Division of Rheumatology, Johns Hopkins University; U. Specks, MD, Division of Pulmonary and Critical Care Medicine; S.R. Ytterberg, MD, Division of Rheumatology, Mayo Clinic College of Medicine; P.A. Merkel, MD, MPH, Division of Rheumatology, University of Pennsylvania; C. Pagnoux, MD, MSc, MPH, Division of Rheumatology, Mount Sinai Hospital.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.141513DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4505809PMC
July 2015

A large-scale genetic analysis reveals a strong contribution of the HLA class II region to giant cell arteritis susceptibility.

Am J Hum Genet 2015 Apr 26;96(4):565-80. Epub 2015 Mar 26.

Instituto de Parasitología y Biomedicina "López-Neyra," CSIC, PTS Granada, Granada 18016, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ajhg.2015.02.009DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4385191PMC
April 2015

New features of disease after diagnosis in 6 forms of systemic vasculitis.

J Rheumatol 2013 Nov 1;40(11):1905-12. Epub 2013 Aug 1.

From The Vasculitis Center, Section of Rheumatology, and the Clinical Epidemiology Unit, Boston University School of Medicine, Boston, Massachusetts; Department of Biostatistics, University of South Florida, Tampa, Florida; Division of Rheumatology, Mount Sinai Hospital, Toronto, Ontario; and the Center for Vasculitis Care and Research, Cleveland Clinic, Cleveland, Ohio; Division of Rheumatology, McMaster University, Hamilton, Ontario, Canada; Division of Rheumatology, University of Utah, Salt Lake City, Utah; Division of Rheumatology, University of Pittsburgh; Division of Rheumatology, Johns Hopkins University, Baltimore, Maryland; Division of Pulmonary and Critical Care Medicine, Mayo Clinic College of Medicine, Rochester; Division of Rheumatology, Mayo Clinic College of Medicine, Rochester, Minnesota; and Division of Rheumatology, University of Pennsylvania, Philadelphia, Pennsylvania, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.121473DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4292850PMC
November 2013

New concepts in the pathogenesis and treatment of vasculitis syndromes.

Authors:
Curry L Koening

Curr Opin Rheumatol 2013 Jan;25(1)

George E. Wahlen Department of Veterans Affairs Medical Center Salt Lake City and University of Utah, Division of Rheumatology, Utah 84132, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/BOR.0b013e32835b65a9DOI Listing
January 2013

Testicular vasculitis: findings differentiating isolated disease from systemic disease in 72 patients.

Medicine (Baltimore) 2012 Mar;91(2):75-85

Department of Autoimmune and Systemic Diseases, Hospital Clínic, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MD.0b013e31824156a7DOI Listing
March 2012

Hepcidin mediates transcriptional changes that modulate acute cytokine-induced inflammatory responses in mice.

J Clin Invest 2010 Jul 7;120(7):2395-405. Epub 2010 Jun 7.

Department of Internal Medicine, School of Medicine, University of Utah, Salt Lake City, Utah 84132, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1172/JCI42011DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2898601PMC
July 2010

Serum chitotriosidase activity and Wegener's granulomatosis.

Clin Biochem 2010 Mar 1;43(4-5):512-4. Epub 2009 Dec 1.

Department of Rheumatic and Immunologic Diseases, Cleveland Clinic Center for Vasculitis Care and Research, Cleveland, OH, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clinbiochem.2009.11.015DOI Listing
March 2010

Surgical interventions and local therapy for Wegener's granulomatosis.

Curr Opin Rheumatol 2010 Jan;22(1):29-36

Department of Autoimmune and Systemic Diseases, Hospital Clínic, IDIBAPS, University of Barcelona, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/BOR.0b013e328333e9e9DOI Listing
January 2010

Persistent hematuria after induction of remission in Wegener granulomatosis: a therapeutic dilemma.

Medicine (Baltimore) 2009 Nov;88(6):315-21

Division of Rheumatology, Metro Health Campus, Case Western Reserve University, Cleveland, OH 44195, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MD.0b013e3181c101ccDOI Listing
November 2009

Hepcidin is elevated in mice injected with Mycoplasma arthritidis.

J Inflamm (Lond) 2009 Nov 24;6:33. Epub 2009 Nov 24.

Division of Hematology, Department of Internal Medicine, University of Utah, School of Medicine, 30 North 1900 East, Salt Lake City, 84132, Utah, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1476-9255-6-33DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2791099PMC
November 2009

Sinonasal Wegener granulomatosis: a single-institution experience with 120 cases.

Laryngoscope 2009 Apr;119(4):757-61

Head and Neck Institute, Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/lary.20161DOI Listing
April 2009

Limited utility of rapamycin in severe, refractory Wegener's granulomatosis.

J Rheumatol 2009 Jan;36(1):116-9

Cleveland Clinic, Center for Vasculitis Care and Research, Department of Rheumatic and Immunologic Diseases, Cleveland, OH, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.080664DOI Listing
January 2009

Takayasu's arteritis.

Curr Treat Options Cardiovasc Med 2008 Apr;10(2):164-72

University of Utah, Division of Rheumatology, Room 4b200 SOM, 1900 East 30 North, Salt Lake City, UT 84132, USA.

View Article

Download full-text PDF

Source
April 2008

Novel therapeutic strategies for large vessel vasculitis.

Rheum Dis Clin North Am 2006 Feb;32(1):173-86, xi

Center for Vasculitis Care and Research, Department of Rheumatic and Immunologic Diseases, The Cleveland Clinic Foundation, Cleveland, OH 44195, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.rdc.2005.09.006DOI Listing
February 2006